D-penicillamine pharmacokinetics and pharmacodynamics in man

Pharmacology & Therapeutics
D A Joyce

Abstract

No abstract listed.

References

Mar 23, 1978·The New England Journal of Medicine·B M Babior
Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·O W Griffith, A Meister
May 20, 1978·Lancet·M RisterE Gladtke
Jan 1, 1978·Scandinavian Journal of Rheumatology·M HaatajaH M Ruutsalo
Jan 1, 1978·Rheumatology and Rehabilitation·P A Bacon
Jan 1, 1979·Biochemical Pharmacology·L Binderup, E Arrigoni-Martelli
Jun 1, 1979·Clinica Chimica Acta; International Journal of Clinical Chemistry·A O MuijsersJ K Van der Korst
Feb 1, 1978·Annals of the Rheumatic Diseases·P R ScudderT L Dormandy
May 1, 1978·British Journal of Pharmacology·F M CunninghamJ R Walker
May 1, 1975·Angewandte Chemie·W M WeigertP Scherberich
Oct 1, 1977·The Journal of Pediatrics·R G Peterson, B H Rumack
Oct 24, 1977·Biochemical and Biophysical Research Communications·M Younes, U Weser
Oct 1, 1976·The Journal of Clinical Investigation·H Chwalinska-Sadowska, J Baum
Aug 1, 1976·Rheumatology and Rehabilitation·E Arrigoni-Martelli, E Bramm
Sep 1, 1976·Agents and Actions·P A DieppeE Arrigoni-Martelli
Jun 13, 1975·Annals of the New York Academy of Sciences·I A Jaffe
Oct 1, 1975·Annals of the Rheumatic Diseases·I MohammedB M Ansell
Apr 1, 1988·European Journal of Drug Metabolism and Pharmacokinetics·A E Pilkington, R H Waring
Feb 1, 1987·Neuropediatrics·S LingamA P Mowat
Jan 1, 1987·Scandinavian Journal of Rheumatology·T AmmitzbøllG Asboe-Hansen
Nov 1, 1985·Clinical and Experimental Pharmacology & Physiology·A Chamson, J Frey
Jan 31, 1985·Biochemical and Biophysical Research Communications·G W Rafter
Nov 15, 1985·Biochemical Pharmacology·J H YeungB K Park
Jan 1, 1986·Annals of the Rheumatic Diseases·J F KosterA J Swaak
Mar 1, 1986·The British Journal of Dermatology·N LightN C Avery

❮ Previous
Next ❯

Citations

Nov 1, 1990·Agents and Actions·D A Joyce, B R Murphy
Aug 2, 2005·Neuro-oncology·Steven BremUNKNOWN New Approaches to Brain Tumor Therapy CNS Consortium
Apr 2, 2009·Expert Opinion on Investigational Drugs·Gazala Khan, Sofia Merajver
Sep 9, 2008·Cancer Treatment Reviews·Anshul Gupte, Russell J Mumper
Jul 24, 2013·Journal of Veterinary Internal Medicine·D K LangloisW D Schall
Sep 30, 1991·The American Journal of Medicine·H Sies
Nov 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·I Sternlieb
Dec 28, 2013·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Sarita RoyAnjan Kr Dasgupta
Oct 1, 1990·Trends in Pharmacological Sciences·H Refsum, P M Ueland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.